🌍 Society & Frontier risk-on · 3–10 years
A what‑if from the future

What if Alzheimer's is reversed?

A new mechanism (beyond amyloid) demonstrably halts or reverses cognitive decline, lifting a vast care-cost burden and extending working healthspan.

32%
our model probability
over 3–10 years
prediction markets — wisdom of the crowd
loading live odds…
Empirically anchored 32% · 90% range 9–54% · 19 analogues · measured class health 84% in 10 yr · 3% held back for the unknown
how we built this number — every step
Measured class rate — health ≈0.1843/yr → 84% in 10 yr84%
Analyst prior · editorial share 30% of the class25%
Pooled · weight 76%33%
Crowd — no liquid market
Reserve 3% · no extremizing (×1.0)33%
Published32%

The class rate is measured from our dated, sourced event library (decade-normalized Poisson — the full table is public at base_rates.json). The variant’s share within its class is the analyst’s editorial call, published so you can audit it. A wider range means thinner precedent. Full recipe: methodology · scored at Reality Check.

The butterfly cascade

How this trigger trickles across markets, left → right — the root shock, its first‑order moves, then the ripple effects. Drag any node; tap a market for its real price history.

Resolution timeline — how this probability is moving

Our model's odds (gold) over time vs the crowd's (Polymarket, blue), from the past toward the 3–10 years horizon. Each dot is a real macro event that nudged the probability — green pushed it up, red pushed it down. Tap a dot for the source. The gold path is an illustrative reconstruction anchored to today's estimate — real dated events, not a live re-estimate history.

loading the timeline…

What it would mean

If this plays out, it is a risk-on shock. A new mechanism (beyond amyloid) demonstrably halts or reverses cognitive decline, lifting a vast care-cost burden and extending working healthspan. The trigger decomposes into signed root‑shocks — Biotech breakthrough ▲ · Labor surplus ▲ · Longevity ▲ — which propagate through our causal graph to the markets below.

If it happens — the markets it would move

Biggest moves first. Projected moves are cascade-model priors; hist A–B% = what comparable past events actually did (measured abnormal returns), and model prior · unmeasured marks markets with no analogue backing yet. Tap any market for its price history.

MarketClassProjected move
1Nasdaq 100 NDXon Hyperliquid 📈 chartIndex▲ +0.4%
hist +0.12–+0.31% · other way +0.23% (n=12)
2Solana SOLon Hyperliquid 📈 chartCrypto▲ +0.4%
hist -14.04–+3.72% · other way -0.91% (n=10)
3S&P 500 SPXon Hyperliquid 📈 chartIndex▲ +0.3%
hist +0.05–+0.31% · other way -2.31% (n=12)
4Hyperliquid (HYPE) HYPEon HyperliquidCrypto▲ +0.3%
model prior · unmeasured
5Tech sector XLK 📈 chartEquity▲ +0.3%
hist -0.11–+0.6% · other way +0.07% (n=12)
6MicroStrategy MSTRon Hyperliquid 📈 chartEquity▲ +0.3%
hist -4.98–+9.69% · other way +14.53% (n=12)
7Ether ETHon Hyperliquid 📈 chartCrypto▲ +0.2%
hist -3.6–+2.13% · other way -3.62% (n=11)
8Bitcoin BTCon Hyperliquid 📈 chartCrypto▲ +0.2%
hist -2.68–+4.75% · other way -0.98% (n=12)
9Semiconductors SMHon Hyperliquid 📈 chartEquity▲ +0.2%
hist -0.49–+1.35% · other way -0.48% (n=12)

Probable recommendation

If the scenario above plays out, the probable cross‑asset positioning → a scenario‑conditional read, not personalized investment advice
Short
For a common-man portfolio: A typical stock-heavy portfolio should benefit. Stay invested; you can lean modestly into the beneficiaries below.
Also moves (not yet on Hyperliquid): Tech sector +0.3%

Historical precedent — what analogous events actually did

Across 19 analogous events (overlap‑weighted), as abnormal returns — market beta stripped, so it's the event's own effect, not the market backdrop. Shown at 20 days (persistent) and 5 days (immediate); ↺ fades = the two horizons disagree. Confidence = consistency × sample × significance.

Wegovy 2021-06 First mRNA COVID-19 vaccine authorized 2020-12 Casgevy — first CRISPR gene-editing medicine approved 2023-12 mRNA pioneers win the Nobel 2023-10 First genetically-modified pig-to-human heart transplant 2022-01 AlphaFold cracks the protein-folding problem 2020-11 Human Genome Project completed 2003-04 Nasdaq Composite first close above 20000 2024-12 Neuralink implants its first human brain-computer interface 2024-01 LK-99 room-temperature superconductor claim 2023-07 Strong May 2023 jobs report jolts yields higher 2023-06 Nvidia AI-guidance blowout ignites the automation/AI capex wave 2023-05 OpenAI releases GPT-4 2023-03 NIF achieves fusion ignition 2022-12 Bank of England's first post-pandemic rate hike 2021-12 AlphaGo defeats Lee Sedol 2016-03 SpaceX lands an orbital rocket booster 2015-12 Bank of Japan Kuroda QQE 'bazooka' 2013-04 Volcker Saturday Night Special 1979-10
AssetHistory saysAbnormal (20d · 5d)HitnConfidencevs cascade
SOL SOLSHORT-12.5% · 5d -9.6%83%14 0.51⚠ differs
US dollar DXYSHORT-0.4% · 5d -0.4%68%19 0.28·
SPX SPXLONG+0.1% · 5d +0.7%62%19 0.22✓ matches cascade
ETH ETHSHORT-3.8% · 5d -6.0%64%14 0.22⚠ differs
10y yield DGS10LONG+12bp · 5d +4bp62%19 0.19·
SMH SMHLONG+1.2% · 5d +1.1%60%18 0.15✓ matches cascade
Bitcoin BTCLONG+4.7% · 5d -4.7% ↺ fades55%16 0.09✓ matches cascade
High-yield credit HYGSHORT-0.1% · 5d -0.2%57%17 0.09·
NDX NDXLONG+0.1% · 5d -0.4% ↺ fades56%18 0.08✓ matches cascade
MSTR MSTRLONG+9.5% · 5d -1.1% ↺ fades53%18 0.06✓ matches cascade
Volatility VIXLONG+2.3% · 5d -4.2% ↺ fades51%18 0.02·
XLK XLKLONG+0.4% · 5d -0.1% ↺ fades49%18 0.00✓ matches cascade
Gold XAULONG+0.0% · 5d -0.1% ↺ fades49%18 0.00·

Methodology. Probability and impact are anchored to history and scored against what actually happens — wins and losses, in public, at Reality Check. Crowd odds live from Polymarket & Kalshi. By Vikas Singh, Quantitative Strategist. Updated 2026-07-03.